COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Identification Sepsis Related Single Nucleotide Polymorphism (SNP) by Whole Exome Sequencing

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01920217
Recruitment Status : Unknown
Verified August 2013 by Huijuan Wang, Chinese PLA General Hospital.
Recruitment status was:  Recruiting
First Posted : August 9, 2013
Last Update Posted : August 9, 2013
Information provided by (Responsible Party):
Huijuan Wang, Chinese PLA General Hospital

Brief Summary:
Sepsis is a common cause of death in intensive care unit, timely and accurate diagnosis and treatment directly affect the survival rate. Single nucleotide polymorphism (SNP) was promising genetic biomarker for sepsis patients. The present study was designed to screen several SNP by whole exome sequencing which evaluate the sepsis related snp site in order to be a new target for the treatment of sepsis.

Condition or disease

Detailed Description:
The study is a non-intervention, prospective observational study. Purpose of this sudy is to screening several SNPs by whole exome sequencing which can be used as genetic marker for sepsis patients. We will collect whole blood samples from patients with sepsis inRespiratory Intensive Care Unit (RICU), the Emergency Intensive Care Unit (EICU), or the Department of Surgery's ICU 301 Hospital since January 2013, and then whole exome sequencing was used to Screen SNPs which were related to sepsis. Then another 500 sepsis patients and 500 normal controls were used to validated the sequencing results.

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1000 participants
Observational Model: Case Control
Time Perspective: Prospective
Target Follow-Up Duration: 28 Days
Official Title: Identification Sepsis Related SNP by Whole Exome Sequencing: a Prospective Observational Study
Study Start Date : January 2013
Estimated Primary Completion Date : January 2015
Estimated Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sepsis

normal control
Sepsis group

Primary Outcome Measures :
  1. sepsis related SNP site [ Time Frame: 28 days after admitted to ICU ]

Biospecimen Retention:   Samples With DNA
whole blood sample

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
within 24 hours after admited in ICU

Inclusion Criteria:

  • Clinical diagnosis of sepsis
  • Patients who agree with the study

Exclusion Criteria:

  • Aged <18 years;
  • Into the group who died within 24 hours;
  • Agranulocytosis (<0.5 × 109 / L);
  • Combined HIV infection.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01920217

Layout table for location contacts
Contact: Huijuan Wang, Dr +86 13466791738

Layout table for location information
China, Beijing
Chinese PLA general hospital Recruiting
Beijing, Beijing, China, 100086
Contact: lixin xie, Dr    +86 1068185281   
Sponsors and Collaborators
Chinese PLA General Hospital
Layout table for investigator information
Study Director: Huijuan Wang, Dr Chinese PLA General Hospital
Additional Information:

Layout table for additonal information
Responsible Party: Huijuan Wang, Dr, Chinese PLA General Hospital Identifier: NCT01920217    
Other Study ID Numbers: 301PLAGH20130610
First Posted: August 9, 2013    Key Record Dates
Last Update Posted: August 9, 2013
Last Verified: August 2013
Keywords provided by Huijuan Wang, Chinese PLA General Hospital:
Additional relevant MeSH terms:
Layout table for MeSH terms
Systemic Inflammatory Response Syndrome
Pathologic Processes